Allergan plc (AGN.N)
18 Apr 2019
Latest Key Developments (Source: Significant Developments)
March 26 (Reuters) - Allergan plc
Allergan Says Believe Appaloosa Attempting To "Undermine Our CEO" And Pushing For A "Firesale" Of Co
March 25 (Reuters) - Allergan plc
March 22 (Reuters) - Allergan plc
March 18 (Reuters) - Allergan plc
Feb 19 (Reuters) - Appaloosa LP::APPALOOSA LP SENDS LETTER TO ALLERGAN BOARD IN RESPONSE TO RESOLUTION TO SEPARATE ROLES OF CHAIRMAN AND CEO.APPALOOSA LP, IN LETTER TO ALLERGAN, SAYS SEEKS A MORE IMMEDIATE SEPARATION OF CHAIR AND CEO.SAYS WILL NOT WITHDRAW ITS ALLERGAN PROPOSALS FROM THIS YEAR’S PROXY STATEMENT.IF ALLERGAN BOARD "UNABLE OR UNWILLING" TO FIND SUITABLE REPLACEMENT, IT IS "FIDUCIARY OBLIGATION" TO EXPLORE OTHER OPTIONS, INCLUDING MERGER/SALE.BOB HUGIN WOULD HAVE BEEN A "CREDIBLE CANDIDATE" FOR ALLERGAN CHAIRMAN GIVEN "HIS STANDING IN THE INDUSTRY". Full Article
Feb 19 (Reuters) - Allergan plc
Feb 12 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt
Allergan Says Board Of Directors Has Received Appaloosa's Proposal And Is "Committed To Continuing To Engage With Them"
Feb 8 (Reuters) - Allergan plc
Jan 11 (Reuters) - Health Canada::HEALTH CANADA - INFORMING CANADIANS THAT ITS SAFETY REVIEW OF FIBRISTAL FOUND POSSIBLE LINK BETWEEN ITS USE & RISK OF A RARE BUT SERIOUS LIVER INJURY.HEALTH CANADA - INITIATED ITS SAFETY REVIEW OF FIBRISTAL AFTER RECEIVING 4 INTERNATIONAL REPORTS OF LIVER INJURY LEADING TO LIVER TRANSPLANTS.HEALTH CANADA - HAS WORKED WITH THE MANUFACTURER TO UPDATE CANADIAN PRODUCT SAFETY INFORMATION FOR FIBRISTAL, WHICH INCLUDE NEW RESTRICTIONS FOR USE. Full Article
Sept 19 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt
Two leading shareholder advisory firms threw their support behind Allergan Plc's management by recommending that investors vote against billionaire investor David Tepper's proposal that the Botox maker immediately split the roles of chief executive officer and chairman.